GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Capital Expenditure

JW Holdings (XKRX:096760) Capital Expenditure : ₩-40,539.75 Mil (TTM As of Mar. 2025)


View and export this data going back to 2007. Start your Free Trial

What is JW Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

JW Holdings's cash flow for capital expenditures for the three months ended in Mar. 2025 was ₩-11,698 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-40,539.75 Mil.

JW Holdings Capital Expenditure Historical Data

The historical data trend for JW Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Holdings Capital Expenditure Chart

JW Holdings Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57,403.54 -43,547.20 -70,109.14 -85,304.39 -35,706.17

JW Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,864.16 -7,655.10 -12,329.96 -8,856.96 -11,697.74

JW Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-40,539.75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JW Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Holdings Corp (XKRX:096760) » Definitions » Capital Expenditure
Comparable Companies
XKRX:007570 XKRX:476060 XKRX:005500 XKRX:067080 XKRX:001630 XKRX:008490 XKRX:000520 XKRX:293480 XKRX:102460 XKRX:092040 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
698 Sindaebang 1-dong, Dongjak-gu, Seoul, KOR, 156-010
Website
http://www.jw-holdings.co.kr
JW Holdings Corp is a healthcare solutions provider. It is a drug manufacturer based in Korea and its key focus areas are raw material, completion medicine, medical supplies and medical appliances. The company's array of products comprises of antimicrobials, antifungals, anticancer and gastrointestinal agents. It licenses and markets in its home country and in regions such as United States, Japan, Germany, and China.

JW Holdings Headlines

No Headlines